Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - CustomersRetained EarningsSecuritiesSecurities BorrowedSecurities BoughtShareholder's EquityShort term DebtTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nomura Holdings (NMR) Cash & Equivalents (2017 - 2025)

Nomura Holdings (NMR) has 16 years of Cash & Equivalents data on record, last reported at $29.0 billion in Q1 2025.

  • For Q1 2025, Cash & Equivalents rose 1.38% year-over-year to $29.0 billion; the TTM value through Mar 2025 reached $29.0 billion, up 1.38%, while the annual FY2025 figure was $29.0 billion, 1.19% down from the prior year.
  • Cash & Equivalents reached $29.0 billion in Q1 2025 per NMR's latest filing, up from $28.6 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $33.2 billion in Q1 2021 and bottomed at $28.5 billion in Q1 2022.
  • Average Cash & Equivalents over 5 years is $29.6 billion, with a median of $28.9 billion recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: increased 13.11% in 2021, then decreased 13.94% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $33.2 billion in 2021, then fell by 13.94% to $28.5 billion in 2022, then grew by 1.22% to $28.9 billion in 2023, then fell by 0.96% to $28.6 billion in 2024, then grew by 1.38% to $29.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $29.0 billion in Q1 2025, $28.6 billion in Q1 2024, and $28.9 billion in Q1 2023.